Edwards Lifesciences Corporation Other than Temporary Impairment Losses, Investments
Edwards Lifesciences Corporation (EW) reported Other than Temporary Impairment Losses, Investments of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfInvestments · last filed 2022-02-14
- Edwards Lifesciences Corporation other than temporary impairment losses, investments for fiscal 2021 was $0.00.
- Edwards Lifesciences Corporation other than temporary impairment losses, investments for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Edwards Lifesciences Corporation other than temporary impairment losses, investments for fiscal 2019 was $40.60M, a 65.82% decline from fiscal 2018.
- Edwards Lifesciences Corporation other than temporary impairment losses, investments for fiscal 2018 was $118.80M, a 283.23% increase from fiscal 2017.
| Period end | Other than Temporary Impairment Losses, Investments 12 month |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-14 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-14 |
| 2019-12-31 | $40.60M 10-K · filed 2022-02-14 |
| 2018-12-31 | $118.80M 10-K · filed 2021-02-12 |
| 2017-12-31 | $31.00M 10-K · filed 2020-02-14 |
| 2016-12-31 | $0.00 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |